| Document and Entity Information | 6 Months Ended |
| Feb. 28, 2014 | |
| Document And Entity Information | ' |
| Entity Registrant Name | 'MIX 1 LIFE, INC. |
| Entity Central Index Key | '0001501112 |
| Document Type | '10-Q |
| Document Period End Date | 28-Feb-14 |
| Amendment Flag | 'false |
| Current Fiscal Year End Date | '--08-31 |
| Is Entity a Well-known Seasoned Issuer? | 'No |
| Is Entity a Voluntary Filer? | 'No |
| Is Entity's Reporting Status Current? | 'Yes |
| Entity Filer Category | 'Smaller Reporting Company |
| Entity Common Stock, Shares Outstanding | 39,482,500 |
| Document Fiscal Period Focus | 'Q2 |
| Document Fiscal Year Focus | '2014 |
| Balance Sheets (USD $) | Feb. 28, 2014 | Aug. 31, 2013 |
| Current Assets: | ' | ' |
| Cash and cash equivalents | $354,377 | ' |
| Other current Assets | 44,070 | ' |
| Total Current Assets | 398,447 | ' |
| Fixed Assets | 5,788 | ' |
| Ingredient Specifications, Branding, and Other Intangible Assets | 19,880,000 | 19,880,000 |
| TOTAL ASSETS | 20,284,235 | 19,880,000 |
| Current Liabilities: | ' | ' |
| Accounts payable and accrued liabilities | 82,378 | 14,055 |
| Accounts payable - related parties | 43,068 | 18,716 |
| Officer Loan | 4,567 | ' |
| Convertible Note Payable | 500,000 | ' |
| Total Current Liabilities | 630,013 | 32,771 |
| Shareholders' Equity: | ' | ' |
| Common Stock, $0.001 par value, 100,000,000 shares authorized 30,279,060 and 39,310,000 shares issued and outstanding at February 28, 2014 and August 31, 2013 respectively | 30,279 | 39,310 |
| Additional paid-in-capital | 20,860,781 | 19,868,690 |
| (Deficit) accumulated during the development stage | -1,236,838 | -60,771 |
| Total Shareholders' Equity | 19,654,222 | 19,847,229 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $20,284,235 | $19,880,000 |
| Balance Sheets (Parenthetical) (USD $) | Feb. 28, 2014 | Aug. 31, 2013 |
| Stockholders' Equity | ' | ' |
| Common stock, par value | $0.00 | $0.00 |
| Common stock, shares authorized | 100,000,000 | 100,000,000 |
| Common stock, shares issued | 30,279,060 | 39,310,000 |
| Common stock, shares outstanding | 30,279,060 | 39,310,000 |
| Statements Of Operations (USD $) | 3 Months Ended | 6 Months Ended | 57 Months Ended | ||
| Feb. 28, 2014 | Feb. 28, 2013 | Feb. 28, 2014 | Feb. 28, 2013 | Feb. 28, 2014 | |
| Operating Expenses | ' | ' | ' | ' | ' |
| Corporate general and administrative | $475,851 | $1,295 | $773,670 | $14,100 | $834,442 |
| Loss from Operations | -475,851 | -1,295 | -773,670 | -14,100 | -834,442 |
| Other (Expenses) | ' | ' | ' | ' | ' |
| Interest expense | -402,396 | ' | -402,396 | ' | -402,396 |
| Loss before income taxes | -878,247 | -1,295 | -1,176,066 | -14,100 | -1,236,838 |
| Provision for Income Taxes | ' | ' | ' | ' | ' |
| Net (Loss) | ($878,247) | ($1,295) | ($1,176,066) | ($14,100) | ($1,236,838) |
| Basic and fully diluted: | ' | ' | ' | ' | ' |
| Weighted average number of shares outstanding | 39,541,351 | 29,310,000 | 39,426,873 | 29,310,000 | ' |
| (Loss) per share | ($0.02) | $0 | ($0.03) | $0 | ' |
| Statements Of Cash Flows (USD $) | 6 Months Ended | 57 Months Ended | |
| Feb. 28, 2014 | Feb. 28, 2013 | Feb. 28, 2014 | |
| Cash flows from operating activities: | ' | ' | ' |
| Net (loss) | ($1,176,066) | ($14,100) | ($1,236,838) |
| Adjustments to reconcile net (loss) to net cash used in operating activities: | ' | ' | ' |
| Common stock issued for services | 194,780 | ' | 194,780 |
| Common stock issued for officers' and directors' fees | 114,000 | ' | 114,000 |
| Commission paid for equity raise | -12,000 | ' | -12,000 |
| Convertible note loan fees | 194,445 | ' | 194,445 |
| Valuation of warrants on convertible debt | 196,835 | ' | 196,835 |
| Changes in Current Assets and Liabilities | ' | ' | ' |
| Other current assets | -44,070 | ' | -44,070 |
| Accounts payable | 68,322 | ' | 82,378 |
| Accounts payable - related parties | 24,352 | ' | 43,068 |
| Net cash (used) in by operating activities | -439,402 | -14,100 | -467,402 |
| Purchase of office equipment | -5,788 | ' | -5,788 |
| Net cash provided by (used in) investing activities | -5,788 | ' | -5,788 |
| Cash flows from financing activities | ' | ' | ' |
| Loans from Officer | 30,400 | ' | 33,400 |
| Repayments to officer | -25,833 | ' | -25,833 |
| Convertible Note proceeds | 500,000 | ' | 500,000 |
| Sale of common stock | 295,000 | ' | 320,000 |
| Net cash provided by financing activities | 799,567 | ' | 827,567 |
| Net increase in cash and cash equivalents | 354,377 | -14,100 | 354,377 |
| Cash and cash equivalents, beginning of year | ' | 14,230 | ' |
| Cash and cash equivalents, end of year | 354,377 | 130 | 354,377 |
| Cash paid during the year for: | ' | ' | ' |
| Interest | 3,617 | 0 | 3,617 |
| Income Taxes | ' | ' | ' |
| Non-cash investing and financing activities: | ' | ' | ' |
| Common stock issued for purchase of Mix1 assets | ' | ' | 19,880,000 |
| Purchase of Mix1 assets | ' | ' | -19,880,000 |
| Forgiveness of debt - Officer | ' | ' | -3,000 |
| Forgiveness of debt contributed to capital | ' | ' | 3,000 |
| Cancellation of Common Stock | -10,000 | ' | -10,000 |
| Cancellation of Common Stock - Paid in Capital | 10,000 | ' | 10,000 |
| Total | ' | $0 | ' |
| Nature of Operations | 6 Months Ended |
| Feb. 28, 2014 | |
| Notes to Financial Statements | ' |
| Note 1 - Nature of Operations | ' |
| Mix1 Life, Inc. (formerly Antaga International Corp) (“the Company”) was incorporated under the laws of the State of Nevada, U.S. on June 10, 2009. The Company is in the development stage as defined under statement on Financial Accounting Standards Accounting Standards Codification FASB ASC 915-205 “Development-Stage Entities.” We are in the business of formulation and distribution of natural ingredient nutritional products designed to have a positive effect on health, wellbeing and improve physical and mental performance. On August 27, 2013, the Company purchased all of the product specifications and branding of Mix1 nutritional products and plans to manufacture and distribute these products nationwide beginning in early 2014. | |
| The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s annual report filed with the SEC on its 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for our interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosure contained in the audited financial statements for the year ended August 31, 2013, as reported in the Form 10-K, have been omitted. | |
| These financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has limited cash and, as yet, has not generated any revenues, raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from investors and/or issuance of common shares. |
| Stock Transactions | 6 Months Ended |
| Feb. 28, 2014 | |
| Notes to Financial Statements | ' |
| Note 2 - Stock Transactions | ' |
| During the six months ending February 28, 2014, the Company sold 590,000 shares of its common stock in a private placement for $0.50 per share. The Company cancelled 10,000,000 shares of its common stock that was returned by a former chief executive officer. |
| Convertible Note | 6 Months Ended |
| Feb. 28, 2014 | |
| Notes to Financial Statements | ' |
| Note 3 - Convertible Note | ' |
| During the quarter the Company entered into a convertible debt agreement with Mill City Ventures for $500,000. Terms of this deal include annual interest rate of 12%, the option to beneficially convert debt into equity was valued at $194,445 or $0.36 per share, and 1,600,000 warrants. The warrants were valued using the Black Scholes valuation method at $196,835. |
| Subsequent Events | 6 Months Ended |
| Feb. 28, 2014 | |
| Notes to Financial Statements | ' |
| Note 4 - Subsequent Events | ' |
| We have evaluated events and transactions after the balance sheet date to the date these financials statements were released for filing. We did not have any material subsequent events that would require disclosure in these financial statements. |
| Stock Transactions (Details Narrative) (USD $) | 6 Months Ended |
| Feb. 28, 2014 | |
| Stock Transactions Details Narrative | ' |
| Sales of common stock | 590,000 |
| Sales of common stock private placement per share | $0.50 |
| Convertible Note (Details Narrative) (USD $) | 3 Months Ended |
| Feb. 28, 2014 | |
| Convertible Note Details Narrative | ' |
| Convertible debt agreement with Mill City Ventures | $500,000 |
| Annual interest rate | 12.00% |
| Beneficially convert debt value | 194,445 |
| Beneficially convert debt per share | $0.36 |
| Beneficially convert debt warrants | 1,600,000 |
| Warrants Black Scholes valuation | $196,835 |
